Medical Cost of Colorectal Cancer Services in Serbia Between 2014 and 2017: National Data Report
Open Access
- 15 May 2019
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 10, 526
Abstract
Medical Cost of Colorectal Cancer Services in Serbia Between 2014 and 2017: National Data ReportKeywords
This publication has 26 references indexed in Scilit:
- Stage at diagnosis and colorectal cancer survival in six high-income countries: A population-based study of patients diagnosed during 2000–2007Acta Oncologica, 2013
- Resource allocation strategies in Southeastern European health policyThe European Journal of Health Economics, 2012
- Progress in colorectal cancer survival in Europe from the late 1980s to the early 21st century: The EUROCARE studyInternational Journal of Cancer, 2011
- Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation StatusJournal of Clinical Oncology, 2011
- Projections of the Cost of Cancer Care in the United States: 2010-2020JNCI: Journal of the National Cancer Institute, 2011
- Economics of cancer related medical care: Worldwide estimates and available domestic evidence2011
- Cancer mortality in Europe, 2000–2004, and an overview of trends since 1975Annals of Oncology, 2009
- Productivity Costs of Cancer Mortality in the United States: 2000–2020JNCI: Journal of the National Cancer Institute, 2008
- Evaluation of Trends in the Cost of Initial Cancer TreatmentJNCI: Journal of the National Cancer Institute, 2008
- Combined Analysis of Efficacy: The Addition of Bevacizumab to Fluorouracil/Leucovorin Improves Survival for Patients With Metastatic Colorectal CancerJournal of Clinical Oncology, 2005